louisiana glp-1 bowel obstruction class action semaglutide vomiting in Ozempic Lawsuit for Blindness, Stomach Paralysis and Injury Claims semaglutide bowel obstruction class action

After propensity scores overlap weighting, 13,965 pairs of GLP1-RA versus DPP4i initiators (cohort entry: 20062022

Your guide on switching from Ozempic to Mounjaro, with cost and dosages plus doctor-recommended weight loss tips from CT Facial Plastics

Meanwhile, orforglipron demonstrated significant weight loss efficacy [8] consistent with injectable GLP-1 medicines

22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.

N = 161,798 after matching GLP-1RA vs diet/exercise consultation Median follow-up: 2 years Key result: Any obesity-associated cancer HR 0.59, 95% CI 0.53-0.67 Site-specific signals: Multiple myeloma HR 0.37 Pancreatic cancer HR 0.40 Endometrial cancer HR 0.42 Colorectal cancer HR 0.49 But remember: This is observational

The number of GLP-1 prescriptions for weight loss in California in 2023 was over 34 times greater than in 2018